IN
Invesco Ltd. cut its PHAT stake below 5%
Invesco Ltd. reported owning 0% of Phathom Pharmaceuticals, Inc. (PHAT) (30,562 shares) in a Schedule 13G filed Nov 10, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 10, 2026
- Source
- Schedule 13G